{
  "DOI": "10.1038/s41431-022-01086-x",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-022-01086-x",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eA Guideline Group (GG) was convened from multiple specialties and patients to develop the first comprehensive schwannomatosis guideline. The GG undertook thorough literature review and wrote recommendations for treatment and surveillance. A modified Delphi process was used to gain approval for recommendations which were further altered for maximal consensus. Schwannomatosis is a tumour predisposition syndrome leading to development of multiple benign nerve-sheath non-intra-cutaneous schwannomas that infrequently affect the vestibulocochlear nerves. Two definitive genes (\u003cjats:italic\u003eSMARCB1\u003c/jats:italic\u003e/\u003cjats:italic\u003eLZTR1\u003c/jats:italic\u003e) have been identified on chromosome 22q centromeric to \u003cjats:italic\u003eNF2\u003c/jats:italic\u003e that cause schwannoma development by a 3-event, 4-hit mechanism leading to complete inactivation of each gene plus \u003cjats:italic\u003eNF2\u003c/jats:italic\u003e. These genes together account for 70–85% of familial schwannomatosis and 30–40% of isolated cases in which there is considerable overlap with mosaic NF2. Craniospinal MRI is generally recommended from symptomatic diagnosis or from age 12–14 if molecularly confirmed in asymptomatic individuals whose relative has schwannomas. Whole-body MRI may also be deployed and can alternate with craniospinal MRI. Ultrasound scans are useful in limbs where typical pain is not associated with palpable lumps. Malignant-Peripheral-Nerve-Sheath-Tumour-MPNST should be suspected in anyone with rapidly growing tumours and/or functional loss especially with \u003cjats:italic\u003eSMARCB1-\u003c/jats:italic\u003erelated schwannomatosis. Pain (often intractable to medication) is the most frequent symptom. Surgical removal, the most effective treatment, must be balanced against potential loss of function of adjacent nerves. Assessment of patients’ psychosocial needs should be assessed annually as well as review of pain/pain medication. Genetic diagnosis and counselling should be guided ideally by both blood and tumour molecular testing.\u003c/jats:p\u003e",
  "alternative-id": [
    "1086"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "7 November 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "4 February 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "7 March 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "1 April 2022"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "All authors of the ERN GENTURIS guideline have provided disclosure statements on all relationships that they have that might be perceived to be a potential source of a competing interests. DGE and RF report receipt of honoraria or consultation fees from AstraZeneca. MK and DGE report receipt of honoraria or consultation fees from Recursion. DGE and EL report receipt of honoraria or consultation fees from Springworks Therapeutics. LP reported receipt of grants/research support from Devyser. NT reports participation in a company sponsored speaker’s bureau from Stryker. DP reports reimbursement of travel expenses for medical conferences by Medtronic and Nevro Corp. All participants of the ERN GENTURIS schwannomatosis Delphi survey have provided disclosure statements on all relationships that they have that might be perceived to be a potential source of a competing interests. HH report receipt of honoraria or consultation fees from Pfizer. BF reports receipt of honoraria from Gruenenthal UK and Gruenenthal Europe."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-8482-5784",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Evans",
      "given": "D. Gareth",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Mostaccioli",
      "given": "Stefania",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pang",
      "given": "David",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Fadzil O Connor",
      "given": "Mary",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pittara",
      "given": "Melpo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Champollion",
      "given": "Nicolas",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wolkenstein",
      "given": "Pierre",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Thomas",
      "given": "Nick",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ferner",
      "given": "Rosalie E.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kalamarides",
      "given": "Michel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Peyre",
      "given": "Matthieu",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Papi",
      "given": "Laura",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Legius",
      "given": "Eric",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Becerra",
      "given": "Juan Luis",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-6546-7248",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "King",
      "given": "Andrew",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Duff",
      "given": "Chris",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-3023-541X",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Stivaros",
      "given": "Stavros",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-7414-7481",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Blanco",
      "given": "Ignacio",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        4,
        1
      ]
    ],
    "date-time": "2022-04-01T03:18:16Z",
    "timestamp": 1648783096000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        7,
        6
      ]
    ],
    "date-time": "2022-07-06T23:06:52Z",
    "timestamp": 1657148812000
  },
  "funder": [
    {
      "DOI": "10.13039/501100001923",
      "award": [
        "1215-200074"
      ],
      "doi-asserted-by": "publisher",
      "name": "DH | NIHR | Health Services Research Programme"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        1,
        22
      ]
    ],
    "date-time": "2024-01-22T18:38:48Z",
    "timestamp": 1705948728060
  },
  "is-referenced-by-count": 10,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "7",
  "issued": {
    "date-parts": [
      [
        2022,
        4,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "7",
    "published-print": {
      "date-parts": [
        [
          2022,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            4,
            1
          ]
        ],
        "date-time": "2022-04-01T00:00:00Z",
        "timestamp": 1648771200000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            4,
            1
          ]
        ],
        "date-time": "2022-04-01T00:00:00Z",
        "timestamp": 1648771200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-022-01086-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01086-x",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01086-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "812-817",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2022,
        4,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        4,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "1086_CR1",
      "unstructured": "Dhamija R, Plotkin S, Asthagiri A, Messiaen L, Babovic-Vuksanovic D. Schwannomatosis. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. editors. GeneReviews((R)). Seattle (WA): University of Washington, Seattle University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."
    },
    {
      "DOI": "10.1136/jnnp-2018-318538",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "1215",
      "journal-title": "J Neurol Neurosurg Psychiatry",
      "key": "1086_CR2",
      "unstructured": "Evans DG, Bowers NL, Tobi S, Hartley C, Wallace AJ, King AT, et al. Schwannomatosis: a genetic and epidemiological study. J Neurol Neurosurg Psychiatry. 2018;89:1215–9.",
      "volume": "89",
      "year": "2018"
    },
    {
      "author": "A Matsuo",
      "first-page": "742",
      "journal-title": "Rinsho Shinkeigaku",
      "key": "1086_CR3",
      "unstructured": "Matsuo A, Tooyama I, Akiguchi I, Kimura J, Kameyama M. A case of schwannomatosis–clinical, pathological and biochemical studies. Rinsho Shinkeigaku. 1991;31:742–5.",
      "volume": "31",
      "year": "1991"
    },
    {
      "DOI": "10.1007/BF00311626",
      "author": "S Iwabuchi",
      "doi-asserted-by": "publisher",
      "first-page": "816",
      "journal-title": "Surg Today",
      "key": "1086_CR4",
      "unstructured": "Iwabuchi S, Tanita T, Koike K, Fujimura S. Familial neurilemmomatosis: report of a case. Surg Today. 1993;23:816–9.",
      "volume": "23",
      "year": "1993"
    },
    {
      "DOI": "10.1212/WNL.46.4.1072",
      "author": "M MacCollin",
      "doi-asserted-by": "publisher",
      "first-page": "1072",
      "journal-title": "Neurology.",
      "key": "1086_CR5",
      "unstructured": "MacCollin M, Woodfin W, Kronn D, Short MP. Schwannomatosis: a clinical and pathologic study. Neurology. 1996;46:1072–9.",
      "volume": "46",
      "year": "1996"
    },
    {
      "DOI": "10.1212/WNL.48.3.787",
      "author": "SM Pulst",
      "doi-asserted-by": "publisher",
      "first-page": "787",
      "journal-title": "Neurology.",
      "key": "1086_CR6",
      "unstructured": "Pulst SM, Riccardi V, Mautner V. Spinal schwannomatosis. Neurology. 1997;48:787–8.",
      "volume": "48",
      "year": "1997"
    },
    {
      "DOI": "10.1159/000245948",
      "author": "P Wolkenstein",
      "doi-asserted-by": "publisher",
      "first-page": "228",
      "journal-title": "Dermatology.",
      "key": "1086_CR7",
      "unstructured": "Wolkenstein P, Benchikhi H, Zeller J, Wechsler J, Revuz J. Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2. Dermatology. 1997;195:228–31.",
      "volume": "195",
      "year": "1997"
    },
    {
      "DOI": "10.1136/jnnp.62.4.361",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "361",
      "journal-title": "J Neurol Neurosurg. Psychiatry",
      "key": "1086_CR8",
      "unstructured": "Evans DG, Mason S, Huson SM, Ponder M, Harding AE, Strachan T. Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study. J Neurol Neurosurg. Psychiatry. 1997;62:361–6.",
      "volume": "62",
      "year": "1997"
    },
    {
      "DOI": "10.1086/301633",
      "author": "LB Jacoby",
      "doi-asserted-by": "publisher",
      "first-page": "1293",
      "journal-title": "Am J Hum Genet",
      "key": "1086_CR9",
      "unstructured": "Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, et al. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet. 1997;61:1293–302.",
      "volume": "61",
      "year": "1997"
    },
    {
      "DOI": "10.1212/01.WNL.0000070184.08740.E0",
      "author": "M MacCollin",
      "doi-asserted-by": "publisher",
      "first-page": "1968",
      "journal-title": "Neurology.",
      "key": "1086_CR10",
      "unstructured": "MacCollin M, Willett C, Heinrich B, Jacoby LB, Acierno JS Jr., Perry A, et al. Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology. 2003;60:1968–74.",
      "volume": "60",
      "year": "2003"
    },
    {
      "DOI": "10.1086/513207",
      "author": "TJ Hulsebos",
      "doi-asserted-by": "publisher",
      "first-page": "805",
      "journal-title": "Am J Hum Genet",
      "key": "1086_CR11",
      "unstructured": "Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet. 2007;80:805–10.",
      "volume": "80",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1399-0004.2008.01060.x",
      "author": "C Boyd",
      "doi-asserted-by": "publisher",
      "first-page": "358",
      "journal-title": "Clin Genet",
      "key": "1086_CR12",
      "unstructured": "Boyd C, Smith MJ, Kluwe L, Balogh A, Maccollin M, Plotkin SR. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet. 2008;74:358–66.",
      "volume": "74",
      "year": "2008"
    },
    {
      "DOI": "10.1136/jmg.2007.056499",
      "author": "KD Hadfield",
      "doi-asserted-by": "publisher",
      "first-page": "332",
      "journal-title": "J Med Genet",
      "key": "1086_CR13",
      "unstructured": "Hadfield KD, Newman WG, Bowers NL, Wallace A, Bolger C, Colley A, et al. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet. 2008;45:332–9.",
      "volume": "45",
      "year": "2008"
    },
    {
      "DOI": "10.1002/humu.20679",
      "author": "R Sestini",
      "doi-asserted-by": "publisher",
      "first-page": "227",
      "journal-title": "Hum Mutat",
      "key": "1086_CR14",
      "unstructured": "Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat. 2008;29:227–31.",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1136/jmg.2010.082420",
      "author": "I Christiaans",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "journal-title": "J Med Genet",
      "key": "1086_CR15",
      "unstructured": "Christiaans I, Kenter SB, Brink HC, van Os TA, Baas F, van den Munckhof P, et al. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas. J Med Genet. 2011;48:93–7.",
      "volume": "48",
      "year": "2011"
    },
    {
      "DOI": "10.1136/jmg.2009.075721",
      "author": "KD Hadfield",
      "doi-asserted-by": "publisher",
      "first-page": "567",
      "journal-title": "J Med Genet",
      "key": "1086_CR16",
      "unstructured": "Hadfield KD, Smith MJ, Trump D, Newman WG, Evans DG. SMARCB1 mutations are not a common cause of multiple meningiomas. J Med Genet. 2010;47:567–8.",
      "volume": "47",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ng.2855",
      "author": "A Piotrowski",
      "doi-asserted-by": "publisher",
      "first-page": "182",
      "journal-title": "Nat Genet",
      "key": "1086_CR17",
      "unstructured": "Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P, et al. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet. 2014;46:182–7.",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.1212/WNL.0000000000001129",
      "author": "MJ Smith",
      "doi-asserted-by": "publisher",
      "first-page": "141",
      "journal-title": "Neurology.",
      "key": "1086_CR18",
      "unstructured": "Smith MJ, Isidor B, Beetz C, Williams SG, Bhaskar SS, Richer W, et al. Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis. Neurology. 2015;84:141–7.",
      "volume": "84",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jamaneurol.2017.1406",
      "author": "ON Pathmanaban",
      "doi-asserted-by": "publisher",
      "first-page": "1123",
      "journal-title": "JAMA Neurol",
      "key": "1086_CR19",
      "unstructured": "Pathmanaban ON, Sadler KV, Kamaly-Asl ID, King AT, Rutherford SA, Hammerbeck-Ward C, et al. Association of genetic predisposition with solitary schwannoma or meningioma in children and young adults. JAMA Neurol. 2017;74:1123–9.",
      "volume": "74",
      "year": "2017"
    },
    {
      "DOI": "10.1212/WNL.0000000000003418",
      "author": "MJ Smith",
      "doi-asserted-by": "publisher",
      "first-page": "87",
      "journal-title": "Neurology.",
      "key": "1086_CR20",
      "unstructured": "Smith MJ, Bowers NL, Bulman M, Gokhale C, Wallace AJ, King AT, et al. Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis. Neurology. 2017;88:87–92.",
      "volume": "88",
      "year": "2017"
    },
    {
      "DOI": "10.1212/01.WNL.0000163982.78900.AD",
      "author": "M MacCollin",
      "doi-asserted-by": "publisher",
      "first-page": "1838",
      "journal-title": "Neurology.",
      "key": "1086_CR21",
      "unstructured": "MacCollin M, Chiocca EA, Evans DG, Friedman JM, Horvitz R, Jaramillo D, et al. Diagnostic criteria for schwannomatosis. Neurology. 2005;64:1838–45.",
      "volume": "64",
      "year": "2005"
    },
    {
      "DOI": "10.1002/ajmg.a.35760",
      "author": "SR Plotkin",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Am J Med Genet A.",
      "key": "1086_CR22",
      "unstructured": "Plotkin SR, Blakeley JO, Evans DG, Hanemann CO, Hulsebos TJ, Hunter-Schaedle K, et al. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria. Am J Med Genet A. 2013;161a:405–16.",
      "volume": "161a",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s00439-018-1909-9",
      "author": "H Kehrer-Sawatzki",
      "doi-asserted-by": "publisher",
      "first-page": "543",
      "journal-title": "Hum Genet",
      "key": "1086_CR23",
      "unstructured": "Kehrer-Sawatzki H, Kluwe L, Friedrich RE, Summerer A, Schäfer E, Wahlländer U, et al. Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas. Hum Genet. 2018;137:543–52.",
      "volume": "137",
      "year": "2018"
    },
    {
      "DOI": "10.1093/neuonc/noy009",
      "author": "C Louvrier",
      "doi-asserted-by": "publisher",
      "first-page": "917",
      "journal-title": "Neuro Oncol",
      "key": "1086_CR24",
      "unstructured": "Louvrier C, Pasmant E, Briand-Suleau A, Cohen J, Nitschké P, Nectoux J, et al. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis. Neuro Oncol. 2018;20:917–29.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41436-018-0384-y",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "1525",
      "journal-title": "Genet Med",
      "key": "1086_CR25",
      "unstructured": "Evans DG, King AT, Bowers NL, Tobi S, Wallace AJ, Perry M, et al. Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testing. Genet Med. 2019;21:1525–33.",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1186/2045-3329-2-17",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "journal-title": "Clin Sarcoma Res",
      "key": "1086_CR26",
      "unstructured": "Evans DG, Huson SM, Birch JM. Malignant peripheral nerve sheath tumours in inherited disease. Clin Sarcoma Res. 2012;2:17.",
      "volume": "2",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10689-019-00138-4",
      "author": "JA Eelloo",
      "doi-asserted-by": "publisher",
      "first-page": "445",
      "journal-title": "Fam Cancer",
      "key": "1086_CR27",
      "unstructured": "Eelloo JA, Smith MJ, Bowers NL, Ealing J, Hulse P, Wylie JP, et al. Multiple primary malignancies associated with a germline SMARCB1 pathogenic variant. Fam Cancer. 2019;18:445–9.",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-17-0590",
      "author": "DGR Evans",
      "doi-asserted-by": "publisher",
      "first-page": "e54",
      "journal-title": "Clin Cancer Res",
      "key": "1086_CR28",
      "unstructured": "Evans DGR, Salvador H, Chang VY, Erez A, Voss SD, Druker H, et al. Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 2 and related disorders. Clin Cancer Res. 2017;23:e54–61.",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s00401-014-1311-1",
      "author": "S Hutter",
      "doi-asserted-by": "publisher",
      "first-page": "449",
      "journal-title": "Acta Neuropathol",
      "key": "1086_CR29",
      "unstructured": "Hutter S, Piro RM, Reuss DE, Hovestadt V, Sahm F, Farschtschi S, et al. Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants. Acta Neuropathol. 2014;128:449–52.",
      "volume": "128",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ejhg.2014.220",
      "author": "I Paganini",
      "doi-asserted-by": "publisher",
      "first-page": "963",
      "journal-title": "Eur J Hum Genet",
      "key": "1086_CR30",
      "unstructured": "Paganini I, Chang VY, Capone GL, Vitte J, Benelli M, Barbetti L, et al. Expanding the mutational spectrum of LZTR1 in schwannomatosis. Eur J Hum Genet. 2015;23:963–8.",
      "volume": "23",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.humpath.2015.04.008",
      "author": "I Paganini",
      "doi-asserted-by": "publisher",
      "first-page": "1226",
      "journal-title": "Hum Pathol",
      "key": "1086_CR31",
      "unstructured": "Paganini I, Sestini R, Cacciatore M, Capone GL, Candita L, Paolello C, et al. Broadening the spectrum of SMARCB1-associated malignant tumors: a case of uterine leiomyosarcoma in a patient with schwannomatosis. Hum Pathol. 2015;46:1226–31.",
      "volume": "46",
      "year": "2015"
    },
    {
      "DOI": "10.1212/01.wnl.0000201190.89751.41",
      "author": "ME Baser",
      "doi-asserted-by": "publisher",
      "first-page": "730",
      "journal-title": "Neurology.",
      "key": "1086_CR32",
      "unstructured": "Baser ME, Friedman JM, Evans DG. Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology. 2006;66:730–2.",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1634/theoncologist.2012-0162",
      "author": "VL Merker",
      "doi-asserted-by": "publisher",
      "first-page": "1317",
      "journal-title": "Oncologist",
      "key": "1086_CR33",
      "unstructured": "Merker VL, Esparza S, Smith MJ, Stemmer-Rachamimov A, Plotkin SR. Clinical features of schwannomatosis: a retrospective analysis of 87 patients. Oncologist. 2012;17:1317–22.",
      "volume": "17",
      "year": "2012"
    },
    {
      "DOI": "10.1186/s13023-019-1176-4",
      "author": "A Alaidarous",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis",
      "key": "1086_CR34",
      "unstructured": "Alaidarous A, Parfait B, Ferkal S, Cohen J, Wolkenstein P, Mazereeuw-Hautier J. Segmental schwannomatosis: characteristics in 12 patients. Orphanet J Rare Dis. 2019;14:207.",
      "volume": "14",
      "year": "2019"
    },
    {
      "DOI": "10.1002/ana.24753",
      "author": "S Farschtschi",
      "doi-asserted-by": "publisher",
      "first-page": "625",
      "journal-title": "Ann Neurol",
      "key": "1086_CR35",
      "unstructured": "Farschtschi S, Mautner VF, Pham M, Nguyen R, Kehrer-Sawatzki H, Hutter S, et al. Multifocal nerve lesions and LZTR1 germline mutations in segmental schwannomatosis. Ann Neurol. 2016;80:625–8.",
      "volume": "80",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.hansur.2017.07.001",
      "author": "G Chick",
      "doi-asserted-by": "publisher",
      "first-page": "378",
      "journal-title": "Hand Surg Rehabil",
      "key": "1086_CR36",
      "unstructured": "Chick G, Victor J, Hollevoet N. Six cases of sporadic schwannomatosis: Topographic distribution and outcomes of peripheral nerve tumors. Hand Surg Rehabil. 2017;36:378–83.",
      "volume": "36",
      "year": "2017"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-17-0595",
      "author": "WD Foulkes",
      "doi-asserted-by": "publisher",
      "first-page": "e62",
      "journal-title": "Clin Cancer Res",
      "key": "1086_CR37",
      "unstructured": "Foulkes WD, Kamihara J, Evans DGR, Brugières L, Bourdeaut F, Molenaar JJ, et al. Cancer surveillance in gorlin syndrome and rhabdoid tumor predisposition syndrome. Clin Cancer Res. 2017;23:e62–7. https://doi.org/10.1158/1078-0432.CCR-17-0595.",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.cancergen.2014.04.001",
      "author": "MJ Smith",
      "doi-asserted-by": "publisher",
      "first-page": "373",
      "journal-title": "Cancer Genet",
      "key": "1086_CR38",
      "unstructured": "Smith MJ, Wallace AJ, Bowers NL, Eaton H, Evans DG. SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors. Cancer Genet. 2014;207:373–8. https://doi.org/10.1016/j.cancergen.2014.04.001.",
      "volume": "207",
      "year": "2014"
    }
  ],
  "reference-count": 38,
  "references-count": 38,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-022-01086-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "30"
}